155 related articles for article (PubMed ID: 16400326)
21. Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases.
Kao CS; Kum JB; Fan R; Grignon DJ; Eble JN; Idrees MT
Pediatr Dev Pathol; 2013; 16(2):80-5. PubMed ID: 23597251
[TBL] [Abstract][Full Text] [Related]
22. Nephrogenic adenomas of the urethra involving the prostate gland: a report of two cases of a lesion that may be confused with prostatic adenocarcinoma.
Young RH
Mod Pathol; 1992 Nov; 5(6):617-20. PubMed ID: 1369796
[TBL] [Abstract][Full Text] [Related]
23. Urothelial tumors with villous morphology: Histomorphology and role of immunohistochemistry in diagnosis.
Mitra S; Chatterjee D; Das A; Gupta K; Radotra BD; Mandal AK
APMIS; 2018 Mar; 126(3):191-200. PubMed ID: 29399882
[TBL] [Abstract][Full Text] [Related]
24. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract][Full Text] [Related]
25. Sporadic hemangioblastoma of the kidney with PAX2 and focal CD10 expression: report of a case.
Jiang JG; Rao Q; Xia QY; Tu P; Lu ZF; Shen Q; Zhang RS; Yu B; Zhou XJ; Shi SS; Shi QL
Int J Clin Exp Pathol; 2013; 6(9):1953-6. PubMed ID: 24040464
[TBL] [Abstract][Full Text] [Related]
26. Nephrogenic adenoma. A report of 15 cases, review of the literature, and comparison with clear cell adenocarcinoma of the urinary tract.
Young RH; Scully RE
Am J Surg Pathol; 1986 Apr; 10(4):268-75. PubMed ID: 3706613
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
[TBL] [Abstract][Full Text] [Related]
28. Tubular adenoma of the urinary tract: a newly described entity.
Kao CS; Epstein JI
Hum Pathol; 2013 Sep; 44(9):1890-4. PubMed ID: 23664485
[TBL] [Abstract][Full Text] [Related]
29. Nephrogenic adenoma.
Amin W; Parwani AV
Pathol Res Pract; 2010 Oct; 206(10):659-62. PubMed ID: 20619548
[TBL] [Abstract][Full Text] [Related]
30. PAX2 expression in Wilms tumors and other childhood neoplasms.
Davis JL; Matsumura L; Weeks DA; Troxell ML
Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
[TBL] [Abstract][Full Text] [Related]
31. Nephrogenic adenoma: a report of 3 unusual cases infiltrating into perinephric adipose tissue.
Diolombi M; Ross HM; Mercalli F; Sharma R; Epstein JI
Am J Surg Pathol; 2013 Apr; 37(4):532-8. PubMed ID: 23426119
[TBL] [Abstract][Full Text] [Related]
32. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
Seibel JL; Prasad S; Weiss RE; Bancila E; Epstein JI
Hum Pathol; 2002 Feb; 33(2):236-41. PubMed ID: 11957151
[TBL] [Abstract][Full Text] [Related]
33. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
34. Nephrogenic adenoma: an immunohistochemical analysis using biotin-free methods.
Ortiz-Rey JA; Antón-Badiola I; Pérez-Pedrosa A; Peteiro-Cancelo Á; González-Carreró J
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):386-91. PubMed ID: 22495376
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of PAX8, PAX2, and cytokeratin in melanomas.
Plotzke JM; Zhao R; Hrycaj SM; Harms PW; Mehra R; Chan MP
J Cutan Pathol; 2021 Oct; 48(10):1246-1251. PubMed ID: 33934372
[TBL] [Abstract][Full Text] [Related]
36. [Pathological and immunohistochemical analyses of 32 cases of nephrogenic adenoma].
Shen Q; Sun LH; Wang JH; Liu LB; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):522-6. PubMed ID: 23939154
[TBL] [Abstract][Full Text] [Related]
37. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.
Legesse T; Matoso A; Epstein JI
Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177
[TBL] [Abstract][Full Text] [Related]
38. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
Olgac S; Hutchinson B; Tickoo SK; Reuter VE
Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
[TBL] [Abstract][Full Text] [Related]
39. SATB2 as a Marker of the Proximal Nephron: Expression in Nephrogenic Adenoma and Correlation With Other Renal Tubular Markers.
Ortiz-Rey JA; Álvarez-Sarria M; Conde-Ferreirós M; Morellón-Baquera R; Bellas-Pereira A; Baltazar ST; García-Acuña S; San-Miguel Fraile P; Suárez-Peñaranda JM; Fernández-Baltar C; Vieytes-Molares M; Domínguez-Arístegui P; Gómez-de María C; Fachal-Bermúdez C; González-Carreró J
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):145-153. PubMed ID: 36744623
[TBL] [Abstract][Full Text] [Related]
40. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?
Cheng L; Cheville JC; Sebo TJ; Eble JN; Bostwick DG
Cancer; 2000 Feb; 88(4):853-61. PubMed ID: 10679655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
